Jeffrey Maki
Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 38 | 2021 | 237 | 7.840 |
Why?
| Contrast Media | 44 | 2024 | 387 | 7.620 |
Why?
| Gadolinium | 22 | 2024 | 77 | 4.970 |
Why?
| Image Enhancement | 23 | 2024 | 165 | 3.940 |
Why?
| Magnetic Resonance Imaging | 36 | 2024 | 3357 | 3.800 |
Why?
| Organometallic Compounds | 13 | 2023 | 104 | 3.420 |
Why?
| Image Interpretation, Computer-Assisted | 12 | 2024 | 253 | 3.170 |
Why?
| Meglumine | 10 | 2023 | 14 | 2.370 |
Why?
| Renal Artery Obstruction | 10 | 2009 | 29 | 1.750 |
Why?
| Lymphedema | 3 | 2017 | 22 | 1.540 |
Why?
| Lymphography | 4 | 2020 | 7 | 1.450 |
Why?
| Gadolinium DTPA | 9 | 2015 | 49 | 1.280 |
Why?
| Imaging, Three-Dimensional | 13 | 2023 | 559 | 1.270 |
Why?
| Sensitivity and Specificity | 19 | 2021 | 1842 | 1.220 |
Why?
| Arteries | 4 | 2016 | 269 | 1.200 |
Why?
| Ferrosoferric Oxide | 3 | 2017 | 22 | 1.160 |
Why?
| Algorithms | 10 | 2018 | 1626 | 1.110 |
Why?
| Liver Cirrhosis | 3 | 2014 | 274 | 1.100 |
Why?
| Water | 5 | 2022 | 441 | 1.090 |
Why?
| Models, Cardiovascular | 4 | 2016 | 193 | 1.070 |
Why?
| Liver Neoplasms | 5 | 2015 | 637 | 1.070 |
Why?
| Peripheral Vascular Diseases | 5 | 2009 | 104 | 1.070 |
Why?
| Prostatic Neoplasms | 2 | 2024 | 996 | 1.060 |
Why?
| Pulmonary Embolism | 2 | 2019 | 211 | 1.040 |
Why?
| Renal Artery | 8 | 2021 | 33 | 1.030 |
Why?
| Image Processing, Computer-Assisted | 12 | 2023 | 740 | 0.930 |
Why?
| Liver | 6 | 2023 | 1835 | 0.930 |
Why?
| Blood Chemical Analysis | 2 | 2016 | 94 | 0.930 |
Why?
| Artificial Intelligence | 2 | 2024 | 233 | 0.910 |
Why?
| Reproducibility of Results | 21 | 2024 | 3047 | 0.890 |
Why?
| Peliosis Hepatis | 1 | 2023 | 2 | 0.850 |
Why?
| Magnetic Resonance Imaging, Cine | 4 | 2014 | 181 | 0.830 |
Why?
| Carcinoma, Hepatocellular | 2 | 2015 | 267 | 0.790 |
Why?
| Sodium-Potassium-Exchanging ATPase | 1 | 2022 | 50 | 0.790 |
Why?
| Lymphatic Vessels | 2 | 2020 | 59 | 0.780 |
Why?
| Rest | 1 | 2022 | 122 | 0.760 |
Why?
| Diagnostic Imaging | 2 | 2022 | 327 | 0.760 |
Why?
| Artifacts | 12 | 2019 | 124 | 0.670 |
Why?
| Patient-Specific Modeling | 2 | 2016 | 39 | 0.620 |
Why?
| Blood Flow Velocity | 4 | 2016 | 413 | 0.620 |
Why?
| Humans | 74 | 2024 | 129078 | 0.560 |
Why?
| Venous Thrombosis | 1 | 2019 | 161 | 0.550 |
Why?
| Blood Vessels | 2 | 2016 | 185 | 0.490 |
Why?
| Computer Simulation | 9 | 2017 | 943 | 0.490 |
Why?
| Middle Aged | 32 | 2019 | 31024 | 0.490 |
Why?
| Software | 2 | 2024 | 612 | 0.480 |
Why?
| Heterocyclic Compounds | 3 | 2023 | 19 | 0.470 |
Why?
| Magnetics | 2 | 2016 | 44 | 0.450 |
Why?
| Radiology Information Systems | 1 | 2014 | 28 | 0.440 |
Why?
| Lymph Node Excision | 1 | 2015 | 166 | 0.440 |
Why?
| Medical Records Systems, Computerized | 1 | 2014 | 91 | 0.430 |
Why?
| User-Computer Interface | 1 | 2014 | 147 | 0.420 |
Why?
| Phantoms, Imaging | 7 | 2018 | 139 | 0.420 |
Why?
| Male | 37 | 2024 | 63248 | 0.410 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 95 | 0.400 |
Why?
| Lymph Nodes | 1 | 2015 | 459 | 0.400 |
Why?
| Documentation | 1 | 2014 | 184 | 0.390 |
Why?
| Blood Proteins | 1 | 2013 | 233 | 0.380 |
Why?
| Elasticity Imaging Techniques | 1 | 2012 | 48 | 0.380 |
Why?
| Hemangiosarcoma | 1 | 2012 | 20 | 0.380 |
Why?
| Aneurysm, False | 1 | 2012 | 46 | 0.370 |
Why?
| Heart Neoplasms | 1 | 2012 | 50 | 0.370 |
Why?
| Oxygen | 1 | 2016 | 913 | 0.370 |
Why?
| Osteitis Deformans | 1 | 2010 | 5 | 0.350 |
Why?
| Coronary Sinus | 1 | 2010 | 7 | 0.350 |
Why?
| Heart | 1 | 2014 | 650 | 0.340 |
Why?
| Anatomy, Cross-Sectional | 1 | 2010 | 11 | 0.340 |
Why?
| Cell Membrane | 1 | 2013 | 729 | 0.340 |
Why?
| Coronary Vessels | 1 | 2012 | 252 | 0.330 |
Why?
| Heart Septal Defects, Atrial | 1 | 2010 | 57 | 0.330 |
Why?
| Skull | 1 | 2010 | 129 | 0.320 |
Why?
| Transducers | 1 | 2009 | 27 | 0.320 |
Why?
| Restraint, Physical | 1 | 2009 | 67 | 0.320 |
Why?
| Prospective Studies | 10 | 2023 | 7070 | 0.320 |
Why?
| Veins | 2 | 2006 | 60 | 0.310 |
Why?
| Abdomen | 3 | 1998 | 116 | 0.310 |
Why?
| Aged | 22 | 2017 | 22068 | 0.300 |
Why?
| Aorta | 2 | 2023 | 410 | 0.290 |
Why?
| Adult | 23 | 2019 | 35423 | 0.290 |
Why?
| Microcirculation | 4 | 1991 | 141 | 0.290 |
Why?
| Female | 33 | 2019 | 68274 | 0.280 |
Why?
| Aorta, Thoracic | 1 | 2010 | 260 | 0.280 |
Why?
| Hematocrit | 1 | 2006 | 93 | 0.270 |
Why?
| Dose-Response Relationship, Drug | 4 | 2016 | 1974 | 0.260 |
Why?
| Radiology | 1 | 2007 | 160 | 0.240 |
Why?
| Respiration | 3 | 2007 | 191 | 0.240 |
Why?
| Aortic Valve Insufficiency | 2 | 2017 | 47 | 0.230 |
Why?
| Mitral Valve Insufficiency | 2 | 2017 | 79 | 0.230 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2024 | 86 | 0.210 |
Why?
| Nephrogenic Fibrosing Dermopathy | 2 | 2015 | 8 | 0.210 |
Why?
| Tomography, X-Ray Computed | 5 | 2018 | 2530 | 0.200 |
Why?
| Prostate | 1 | 2024 | 173 | 0.200 |
Why?
| Activation, Metabolic | 1 | 2022 | 4 | 0.200 |
Why?
| Injections, Intravenous | 3 | 2019 | 200 | 0.200 |
Why?
| Constriction, Pathologic | 2 | 2021 | 230 | 0.190 |
Why?
| Carotid Arteries | 2 | 2007 | 207 | 0.190 |
Why?
| Observer Variation | 4 | 2018 | 322 | 0.190 |
Why?
| Thorax | 2 | 2019 | 41 | 0.190 |
Why?
| ROC Curve | 3 | 2014 | 501 | 0.190 |
Why?
| Feasibility Studies | 4 | 2019 | 860 | 0.190 |
Why?
| Echocardiography | 2 | 2017 | 634 | 0.190 |
Why?
| Angiography, Digital Subtraction | 4 | 2021 | 45 | 0.180 |
Why?
| Swine | 1 | 2023 | 740 | 0.180 |
Why?
| Lymphatic System | 1 | 2020 | 11 | 0.170 |
Why?
| Benchmarking | 1 | 2021 | 174 | 0.170 |
Why?
| Phlebography | 2 | 2019 | 36 | 0.170 |
Why?
| Motion | 3 | 2009 | 100 | 0.160 |
Why?
| Monte Carlo Method | 2 | 2017 | 142 | 0.160 |
Why?
| Brain Mapping | 1 | 2022 | 564 | 0.150 |
Why?
| Radiation Exposure | 1 | 2019 | 48 | 0.150 |
Why?
| Pelvis | 1 | 2019 | 102 | 0.150 |
Why?
| Models, Statistical | 2 | 2015 | 627 | 0.150 |
Why?
| Cardiac Imaging Techniques | 1 | 2017 | 21 | 0.150 |
Why?
| Computed Tomography Angiography | 1 | 2019 | 115 | 0.140 |
Why?
| Predictive Value of Tests | 4 | 2017 | 1968 | 0.140 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 108 | 0.140 |
Why?
| Glucose | 1 | 2022 | 976 | 0.140 |
Why?
| Aged, 80 and over | 6 | 2008 | 7063 | 0.140 |
Why?
| Total Quality Management | 1 | 2017 | 61 | 0.140 |
Why?
| Radiation Dosage | 2 | 2018 | 159 | 0.130 |
Why?
| Computer-Aided Design | 1 | 2016 | 41 | 0.130 |
Why?
| Injections, Intra-Arterial | 1 | 2016 | 25 | 0.130 |
Why?
| Surface-Active Agents | 1 | 2017 | 82 | 0.130 |
Why?
| Practice Guidelines as Topic | 2 | 2014 | 1526 | 0.130 |
Why?
| Arteriovenous Malformations | 1 | 2016 | 29 | 0.130 |
Why?
| Printing, Three-Dimensional | 1 | 2016 | 81 | 0.130 |
Why?
| Positron-Emission Tomography | 1 | 2017 | 285 | 0.120 |
Why?
| Diffusion | 4 | 1991 | 118 | 0.120 |
Why?
| Prenatal Diagnosis | 1 | 2017 | 189 | 0.120 |
Why?
| Blood | 1 | 2015 | 99 | 0.120 |
Why?
| Sarcoidosis | 1 | 2017 | 151 | 0.120 |
Why?
| Hydrogen-Ion Concentration | 1 | 2016 | 542 | 0.120 |
Why?
| Plasma | 1 | 2016 | 198 | 0.120 |
Why?
| Single-Blind Method | 1 | 2015 | 273 | 0.120 |
Why?
| Software Validation | 1 | 2014 | 8 | 0.110 |
Why?
| Microcomputers | 1 | 2014 | 16 | 0.110 |
Why?
| Software Design | 1 | 2014 | 24 | 0.110 |
Why?
| Diagnosis, Differential | 3 | 2016 | 1435 | 0.110 |
Why?
| Surgery, Computer-Assisted | 1 | 2015 | 76 | 0.110 |
Why?
| Magnetic Fields | 1 | 2013 | 22 | 0.110 |
Why?
| Radiography | 2 | 2014 | 864 | 0.110 |
Why?
| Transposition of Great Vessels | 1 | 2014 | 34 | 0.110 |
Why?
| Electric Impedance | 1 | 2013 | 102 | 0.110 |
Why?
| Protons | 1 | 2013 | 80 | 0.110 |
Why?
| Information Storage and Retrieval | 1 | 2014 | 106 | 0.110 |
Why?
| Cardiomyopathies | 1 | 2017 | 333 | 0.100 |
Why?
| Kidney | 2 | 2012 | 1330 | 0.100 |
Why?
| Drug Design | 1 | 2014 | 156 | 0.100 |
Why?
| Cerebrovascular Circulation | 2 | 1991 | 223 | 0.100 |
Why?
| Angiography | 3 | 2004 | 200 | 0.100 |
Why?
| Pulmonary Artery | 1 | 2018 | 1095 | 0.100 |
Why?
| Elastic Modulus | 1 | 2012 | 123 | 0.100 |
Why?
| Echocardiography, Doppler | 1 | 2012 | 111 | 0.100 |
Why?
| Diagnostic Errors | 1 | 2012 | 163 | 0.090 |
Why?
| Animals | 8 | 2023 | 34708 | 0.090 |
Why?
| Leg | 2 | 2004 | 241 | 0.090 |
Why?
| Cerebral Infarction | 1 | 1991 | 42 | 0.090 |
Why?
| Cardiac Valve Annuloplasty | 1 | 2010 | 2 | 0.090 |
Why?
| Tricuspid Valve | 1 | 2010 | 28 | 0.090 |
Why?
| Time Factors | 5 | 2017 | 6579 | 0.090 |
Why?
| Tricuspid Valve Insufficiency | 1 | 2010 | 26 | 0.090 |
Why?
| Carbon Dioxide | 2 | 1991 | 261 | 0.090 |
Why?
| Pericardium | 1 | 2010 | 54 | 0.090 |
Why?
| Equipment Design | 2 | 2009 | 523 | 0.090 |
Why?
| Fourier Analysis | 3 | 2007 | 39 | 0.080 |
Why?
| Bone Remodeling | 1 | 2010 | 71 | 0.080 |
Why?
| Case-Control Studies | 1 | 2017 | 3336 | 0.080 |
Why?
| Guideline Adherence | 1 | 2014 | 528 | 0.080 |
Why?
| Kidney Failure, Chronic | 1 | 2015 | 549 | 0.080 |
Why?
| Hypertension, Renal | 1 | 2009 | 18 | 0.080 |
Why?
| Ventricular Function, Left | 1 | 2012 | 526 | 0.080 |
Why?
| Spin Labels | 1 | 2009 | 44 | 0.080 |
Why?
| Equipment Failure Analysis | 1 | 2009 | 132 | 0.080 |
Why?
| Young Adult | 3 | 2016 | 12310 | 0.080 |
Why?
| Kidney Diseases | 1 | 2012 | 366 | 0.070 |
Why?
| Scattering, Radiation | 1 | 2007 | 98 | 0.070 |
Why?
| Models, Structural | 3 | 1991 | 40 | 0.070 |
Why?
| Adolescent | 4 | 2016 | 20241 | 0.070 |
Why?
| Pentetic Acid | 2 | 1997 | 12 | 0.070 |
Why?
| Heart Valve Diseases | 1 | 2009 | 170 | 0.070 |
Why?
| Infusions, Intravenous | 2 | 1998 | 395 | 0.070 |
Why?
| Brain | 4 | 1991 | 2604 | 0.060 |
Why?
| Vena Cava, Inferior | 1 | 2006 | 68 | 0.060 |
Why?
| Electrocardiography | 1 | 2009 | 603 | 0.060 |
Why?
| Drug Combinations | 2 | 1997 | 327 | 0.060 |
Why?
| Adrenal Gland Neoplasms | 1 | 2006 | 84 | 0.060 |
Why?
| Arterial Occlusive Diseases | 1 | 2004 | 79 | 0.060 |
Why?
| Vascular Diseases | 1 | 2007 | 241 | 0.060 |
Why?
| Lung | 1 | 2017 | 3925 | 0.050 |
Why?
| Atherosclerosis | 1 | 2007 | 392 | 0.050 |
Why?
| Tomography, Spiral Computed | 1 | 2002 | 27 | 0.050 |
Why?
| Hepatic Artery | 1 | 2002 | 58 | 0.050 |
Why?
| Thrombosis | 1 | 2006 | 331 | 0.050 |
Why?
| Hypertension, Renovascular | 3 | 2009 | 13 | 0.050 |
Why?
| Retrospective Studies | 3 | 2017 | 14562 | 0.050 |
Why?
| Kidney Neoplasms | 1 | 2006 | 352 | 0.050 |
Why?
| Rats | 5 | 1991 | 5254 | 0.040 |
Why?
| Neck | 1 | 1998 | 92 | 0.040 |
Why?
| Rats, Inbred Strains | 3 | 1991 | 365 | 0.030 |
Why?
| Head | 1 | 1998 | 96 | 0.030 |
Why?
| Fetal Organ Maturity | 1 | 2017 | 27 | 0.030 |
Why?
| Ultrasonography | 2 | 2014 | 727 | 0.030 |
Why?
| Heart Failure | 1 | 2010 | 2142 | 0.030 |
Why?
| Forms and Records Control | 1 | 2017 | 21 | 0.030 |
Why?
| Technology Assessment, Biomedical | 1 | 2016 | 31 | 0.030 |
Why?
| United States | 1 | 2014 | 13992 | 0.030 |
Why?
| Rheology | 2 | 2002 | 91 | 0.030 |
Why?
| Ferric Compounds | 1 | 1997 | 45 | 0.030 |
Why?
| Safety | 1 | 1998 | 330 | 0.030 |
Why?
| Efficiency, Organizational | 1 | 2017 | 131 | 0.030 |
Why?
| Treatment Outcome | 1 | 2010 | 10256 | 0.030 |
Why?
| Follow-Up Studies | 2 | 2017 | 4927 | 0.030 |
Why?
| Linear Models | 2 | 2002 | 818 | 0.030 |
Why?
| Product Surveillance, Postmarketing | 1 | 2015 | 65 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 1998 | 616 | 0.030 |
Why?
| Liver Transplantation | 1 | 2002 | 801 | 0.030 |
Why?
| Kidney Function Tests | 1 | 2015 | 149 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2017 | 511 | 0.030 |
Why?
| Physical Examination | 1 | 2016 | 238 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2017 | 861 | 0.030 |
Why?
| Gestational Age | 1 | 2017 | 857 | 0.030 |
Why?
| Carotid Artery Diseases | 1 | 2013 | 64 | 0.030 |
Why?
| Cerebrovascular Disorders | 1 | 2013 | 91 | 0.030 |
Why?
| Contraindications | 1 | 2012 | 90 | 0.030 |
Why?
| Fetus | 1 | 2017 | 764 | 0.020 |
Why?
| Body Water | 1 | 1991 | 19 | 0.020 |
Why?
| Acetone | 1 | 1991 | 11 | 0.020 |
Why?
| Edetic Acid | 1 | 1991 | 47 | 0.020 |
Why?
| Lasers | 1 | 1991 | 131 | 0.020 |
Why?
| Chronic Disease | 1 | 2017 | 1717 | 0.020 |
Why?
| Gels | 1 | 1991 | 83 | 0.020 |
Why?
| Dextrans | 1 | 1991 | 82 | 0.020 |
Why?
| Rats, Inbred F344 | 1 | 1991 | 251 | 0.020 |
Why?
| Muscles | 1 | 1991 | 322 | 0.020 |
Why?
| Corpus Striatum | 1 | 1991 | 153 | 0.020 |
Why?
| Child | 1 | 2010 | 20860 | 0.020 |
Why?
| Stroke Volume | 1 | 2012 | 587 | 0.020 |
Why?
| In Vitro Techniques | 1 | 1991 | 1061 | 0.020 |
Why?
| Cerebral Cortex | 1 | 1991 | 414 | 0.020 |
Why?
| Glomerular Filtration Rate | 1 | 2012 | 685 | 0.020 |
Why?
| Whole Body Imaging | 1 | 2007 | 20 | 0.020 |
Why?
| Risk Assessment | 1 | 2017 | 3290 | 0.020 |
Why?
| Carotid Stenosis | 1 | 2007 | 85 | 0.020 |
Why?
| Leiomyosarcoma | 1 | 2006 | 27 | 0.020 |
Why?
| Myocardial Infarction | 1 | 2013 | 1031 | 0.020 |
Why?
| Clinical Protocols | 1 | 2006 | 256 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2012 | 2768 | 0.010 |
Why?
| Pregnancy | 1 | 2017 | 6256 | 0.010 |
Why?
| Prognosis | 1 | 2012 | 3793 | 0.010 |
Why?
| Reference Standards | 1 | 2004 | 169 | 0.010 |
Why?
| Models, Biological | 1 | 1991 | 1704 | 0.010 |
Why?
| Microscopy, Phase-Contrast | 1 | 2002 | 16 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2002 | 425 | 0.010 |
Why?
| Portal Vein | 1 | 2002 | 106 | 0.010 |
Why?
| Risk Factors | 1 | 2015 | 9804 | 0.010 |
Why?
| Movement | 1 | 2002 | 269 | 0.010 |
Why?
| Liver Diseases | 1 | 2002 | 284 | 0.010 |
Why?
| Regional Blood Flow | 1 | 2002 | 463 | 0.010 |
Why?
| Adenocarcinoma | 1 | 2006 | 898 | 0.010 |
Why?
| Models, Theoretical | 1 | 2002 | 550 | 0.010 |
Why?
| Half-Life | 1 | 1997 | 148 | 0.010 |
Why?
| Reference Values | 1 | 1997 | 791 | 0.010 |
Why?
| Body Temperature | 1 | 1991 | 215 | 0.010 |
Why?
| Death | 1 | 1991 | 124 | 0.010 |
Why?
| Cell Death | 1 | 1991 | 344 | 0.010 |
Why?
|
|
Maki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|